Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Biosense Webster unveils new version of CARTO 3 Electro-Anatomical Mapping System

Written By Ruchika Sharma11 May 2024 4:12 PM IST

Irvine: Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, has announced the...

Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint: Merck

Written By Ruchika Sharma11 May 2024 12:41 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA,...

Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO

Written By Ruchika Sharma11 May 2024 11:30 AM IST

Bengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their...

Granules India packaging facility in US successfully completes USFDA inspection

Aurobindo Pharma subsidiary API facility gets one USFDA observation

Written By Ruchika Sharma10 May 2024 5:43 PM IST

Hyderabad: Through a recent BSE filing, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) has concluded...

Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources

Strides Pharma Science arm gets USFDA nod for Hypocalcemia drug Sevelamer Carbonate

Written By Ruchika Sharma10 May 2024 4:23 PM IST

Sevelamer Carbonate is a phosphate binder, that helps prevent hypocalcemia (low levels of calcium in the body) caused by elevated phosphorus.

Zydus Wellness Arm Faces Rs 6.3 Million GST Penalty Over ITC Irregularities

Zydus Lifesciences completes enrolment for EPICS III Phase 2b/3 trial evaluating Saroglitazar Mg for Primary Biliary Cholangitis

Written By Ruchika Sharma10 May 2024 11:56 AM IST

Saroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.

Zydus Lifesciences bags USFDA nod for acne drug Isotretinoin

Zydus Lifesciences bags USFDA nod for Dapsone Gel for acne treatment

Written By Ruchika Sharma9 May 2024 2:52 PM IST

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Dapsone...

USFDA approves Alembic Pharma five products in over a month

Written By Ruchika Sharma9 May 2024 1:05 PM IST

Mumbai: Alembic Pharmaceuticals Limited announced today that it has received US Food & Drug Administration (USFDA) approvals on five of its...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Cipla gets 1 inspectional observation from USFDA for Maha facility

Written By Ruchika Sharma9 May 2024 11:06 AM IST

Mumbai: Pharma giant Cipla has informed through a recent BSE filing that the Company has received 1 inspectional observation in Form 483...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

KKR to buy Healthium Medtech from Apax Funds

Written By Ruchika Sharma7 May 2024 12:22 PM IST

Mumbai: KKR, a global investment firm, has announced the signing of definitive agreements under which funds managed by KKR will acquire Healthium...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin bags USFDA nod for Travoprost Ophthalmic Solution

Written By Ruchika Sharma7 May 2024 11:43 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....

"Safety is primary focus for all our vaccines": Covaxin-developer Bharat Biotech

Written By Ruchika Sharma6 May 2024 4:07 PM IST

New Delhi: Developer of Covaxin, Bharat Biotech, said in a statement that Covaxin was developed with a "single-minded focus on...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok